Universal Medicare Private Limited

Produces and distributes nutraceutical products including health supplements, cardiac care, and dermaceuticals.

1971 | Mumbai, Maharashtra (India) | Active
Last Updated: October 24, 2024

Universal Medicare Profile

Key Indicators

  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 2.55 Cr
  • Company Age 53 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 0.30 M
  • Satisfied Charges ₹ 76.10 Cr
  • Revenue Growth -34.09%
  • Profit Growth -83.43%
  • Ebitda -73.49%
  • Net Worth -0.05%
  • Total Assets -1.61%

About Universal Medicare

Universal Medicare Private Limited (UMPL) was founded in India on 12 August 1971 and has a glorious history of 53 years and six months. Its registered office is in Mumbai, Maharashtra, India.

The Corporate was formerly known as Universal Medicare Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.55 Cr.

The company currently has active open charges totaling ₹0.30 M. The company has closed loans amounting to ₹76.10 Cr, as per Ministry of Corporate Affairs (MCA) records.

Vikram Tannan, Vivek Tannan, Rakesh Khanna, and Three other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    universalmedicare.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239MH1971PTC015282

  • Company No.

    015282

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    12 Aug 1971

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Universal Medicare?

Board Members (6)

NameDesignationAppointment DateStatus
Preetika Tanan Country flag representing In Director 17-Dec-2013Current
Bharat Raut Country flag representing In Director 04-Apr-2007Current
Vikram Tannan Country flag representing In Director 12-Aug-1971Current
Vivek Tannan Country flag representing In Director 22-May-2000Current
Rakesh Khanna Country flag representing In Director 13-Aug-2005Current
Gaurav Sharma Country flag representing In Director 19-Jun-2018Current

Financial Performance of Universal Medicare.

Universal Medicare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.09% decrease. The company also saw a substantial fall in profitability, with a 83.43% decrease in profit. The company's net worth dipped by a decrease of 0.05%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-34.09%
Revenue from Operations
-33.82%
Total Assets
-1.61%
Profit or Loss
-83.43%
Net Worth
-0.05%
EBITDA
-73.49%

What is the Ownership and Shareholding Structure of Universal Medicare?

In 2023, Universal Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0.03 Cr

Satisfied Charges

₹76.10 Cr

Charges Breakdown by Lending Institutions

  • The Saraswat Co- Op. Bank Ltd. : 0.03 Cr

Latest Charge Details

DateLenderAmountStatus
20 Apr 2001The Saraswat Co- Op. Bank Ltd.₹0.30 MOpen
21 Jan 2019Others₹25.55 CrSatisfied
29 Apr 2016Standard Chartered Bank₹15.00 CrSatisfied
09 Mar 2015Kotak Mahindra Bank Limited₹5.00 CrSatisfied
11 May 2009Hsbc Bank (Mauritius) Limited₹9.41 CrSatisfied

How Many Employees Work at Universal Medicare?

Universal Medicare has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Universal Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Medicare's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Universal Medicare

Recent activity within the organization

  • Annual General Meeting

    Universal Medicare Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Universal Medicare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Charges

    A charge registered on 21 Jan 2019 via Charge ID 100243087 with Others was fully satisfied on 09 Apr 2021.

    09 Apr 2021

  • Charges

    A charge registered on 09 Mar 2015 via Charge ID 10559013 with Kotak Mahindra Bank Limited was fully satisfied on 09 Apr 2021.

    09 Apr 2021

  • Charges

    A charge registered on 29 Apr 2016 via Charge ID 100028485 with Standard Chartered Bank was fully satisfied on 23 Dec 2019.

    23 Dec 2019

  • Charges

    A charge with Others amounted to Rs. 25.55 Cr with Charge ID 100243087 was registered on 21 Jan 2019.

    21 Jan 2019

Frequently asked questions

  • Universal Medicare Private Limited was incorporated on 12 Aug 1971.

  • The authorized share capital of Universal Medicare Private Limited is ₹ 4.00 Cr and paid-up capital is ₹ 2.55 Cr.

  • Currently 6 directors are associated with Universal Medicare Private Limited.

    • Vikram Bodhraj Tannan
    • Vivek Vikram Tannan
    • Rakesh Khanna
    • Bharat Sumant Raut
    • Preetika Vikram Tanan
    • Gaurav Sharma
  • As per Ministry of Corporate Affairs (Mca), the registered address of Universal Medicare Private Limited is Capsulation Premisession Trombay Road Deonar India, Mumbai, Maharashtra, 400088.

  • The corporate identification number (CIN) of Universal Medicare Private Limited is U24239MH1971PTC015282 and the company number is 015282 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Universal Medicare Private Limited is https://www.universalmedicare.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Universal Medicare Private Limited has fallen by -34.09%.

  • As Per 2023 financial reports, 4 employees are currently employed by Universal Medicare Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Universal Medicare Private Limited has experienced an downturn of -0.05%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Universal Medicare Private Limited amount to ₹ 0.30 M.

  • The most recent Balance Sheet for Universal Medicare Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development